BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
February 20 2020 - 8:00AM
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly
growing specialty pharmaceutical company dedicated to patients
living with serious and complex chronic conditions, today announced
that it will report its fourth quarter and full year 2019 financial
results after the close of the U.S. financial markets
on Thursday, March 12, 2020. The company will host a
conference call and webcast at 4:30 PM Eastern Time to discuss
the results and provide an update on business operations.
Conference Call Dial-In & Webcast
Information:
Date: |
Thursday, March 12, 2020 |
Time: |
4:30 PM Eastern Time |
Domestic: |
877-407-0789 |
International: |
201-689-8562 |
Conference ID: |
13699178 |
Webcast: |
http://public.viavid.com/index.php?id=138131 |
About BioDelivery Sciences
International, Inc.BioDelivery Sciences International,
Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical
company dedicated to patients living with chronic conditions. BDSI
has built a portfolio of products that includes utilizing its novel
and proprietary BioErodible MucoAdhesive (BEMA®) technology to
develop and commercialize, either on its own or in partnership with
third parties, new applications of proven therapies aimed at
addressing important unmet medical needs. BDSI's marketed products
address serious and debilitating conditions, including chronic
pain, opioid dependence, and opioid-induced constipation.
© 2020 BioDelivery Sciences International,
Inc. All rights reserved.
Contact:Tirth T. PatelDirector
of Investor Relationstpatel@bdsi.com(919) 582-0294
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Apr 2023 to Apr 2024